Picture of Balchem logo

BCPC — Balchem News Story

0.000.00%
us flag iconLast trade - 00:00
Basic MaterialsConservativeLarge CapHigh Flyer

Balchem Q2 sales beat estimates on growth across segments

Balchem Q2 sales beat estimates on growth across segments


Overview

  • US specialty ingredients maker's fiscal Q2 sales rose 11% yr/yr, beating analyst expectations

  • Company achieved record sales and earnings in all segments, driven by growth across businesses

  • Balchem repurchased $29 mln of stock and expanded its credit facility during the quarter


Outlook

  • Balchem says it remains confident in its long-term growth outlook


Result Drivers

  • HUMAN NUTRITION GROWTH - Higher sales in nutrients and food ingredients drove record results in Human Nutrition and Health segment

  • ANIMAL NUTRITION DEMAND - Higher sales in both monogastric and ruminant markets boosted Animal Nutrition and Health segment

  • SPECIALTY PRODUCTS SALES - Increased sales in performance gases and plant nutrition supported Specialty Products segment growth


Company press release: ID:nGNXxHDrq


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Sales

Beat

$284 mln

$268.50 mln (3 Analysts)

Q2 Adjusted EPS

Beat

$1.49

$1.40 (2 Analysts)

Q2 EPS

$1.39

Q2 Net Income

$44.60 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the specialty chemicals peer group is "buy"

  • Wall Street's median 12-month price target for Balchem Corp is $202.50, about 24.4% above its July 30 closing price of $162.73

  • The stock recently traded at 27 times the next 12-month earnings vs. a P/E of 30 three months ago


Reuters Recommended Reads

  • July 30 - Quaker Houghton Q2 adjusted EPS beats estimates, announces $250 mln buyback

  • July 30 - Huntsman Q2 revenue beats analyst expectations on higher volumes and pricing

  • July 30 - Air Products beats quarterly profit estimates, raises annual forecast


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Balchem

See all news